166 related articles for article (PubMed ID: 38501199)
41. Drug-induced interstitial lung disease in tyrosine kinase inhibitor therapy for non-small cell lung cancer: a review on current insight.
Min JH; Lee HY; Lim H; Ahn MJ; Park K; Chung MP; Lee KS
Cancer Chemother Pharmacol; 2011 Nov; 68(5):1099-109. PubMed ID: 21913033
[TBL] [Abstract][Full Text] [Related]
42. Unclassifiable interstitial lung disease: from phenotyping to possible treatments.
Guler SA; Ryerson CJ
Curr Opin Pulm Med; 2018 Sep; 24(5):461-468. PubMed ID: 30004990
[TBL] [Abstract][Full Text] [Related]
43. The epidemiology of interstitial lung disease and its association with lung cancer.
Raghu G; Nyberg F; Morgan G
Br J Cancer; 2004 Aug; 91 Suppl 2(Suppl 2):S3-10. PubMed ID: 15340372
[TBL] [Abstract][Full Text] [Related]
44. Drug-Gene Risk Stratification in Patients with Suspected Drug-Induced Interstitial Lung Disease.
Drent M; Wijnen PA; Jessurun NT; Harmsze AM; Bekers O; Bast A
Drug Saf; 2024 Apr; 47(4):355-363. PubMed ID: 38460070
[TBL] [Abstract][Full Text] [Related]
45. Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease.
Adegunsoye A; Vij R; Noth I
Chest; 2019 May; 155(5):1026-1040. PubMed ID: 30660786
[TBL] [Abstract][Full Text] [Related]
46. An integrated approach in the diagnosis of smoking-related interstitial lung diseases.
Caminati A; Cavazza A; Sverzellati N; Harari S
Eur Respir Rev; 2012 Sep; 21(125):207-17. PubMed ID: 22941885
[TBL] [Abstract][Full Text] [Related]
47. Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease: Data From the Pulmonary Fibrosis Foundation Patient Registry.
Lee J; White E; Freiheit E; Scholand MB; Strek ME; Podolanczuk AJ; Patel NM;
Chest; 2022 Sep; 162(3):603-613. PubMed ID: 35337809
[TBL] [Abstract][Full Text] [Related]
48. Treatment of acute exacerbations of interstitial lung disease.
Azadeh N; Moua T; Baqir M; Ryu JH
Expert Rev Respir Med; 2018 Apr; 12(4):309-313. PubMed ID: 29486130
[TBL] [Abstract][Full Text] [Related]
49. Estimating the incidence of interstitial lung diseases in the Cree of Eeyou Istchee, northern Québec.
Storme M; Semionov A; Assayag D; Lefson M; Kitty D; Dannenbaum D; Torrie J; Lejeune P; Robinson E; Ahmad Khan F
PLoS One; 2017; 12(9):e0184548. PubMed ID: 28886193
[TBL] [Abstract][Full Text] [Related]
50. Current best clinical practices for monitoring of interstitial lung disease.
Bendstrup E; Kronborg-White S; Møller J; Prior TS
Expert Rev Respir Med; 2022; 16(11-12):1153-1166. PubMed ID: 36572644
[TBL] [Abstract][Full Text] [Related]
51. Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management.
Dai Y; Wang W; Yu Y; Hu S
Clin Rheumatol; 2021 Apr; 40(4):1211-1220. PubMed ID: 32794076
[TBL] [Abstract][Full Text] [Related]
52. Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients.
Eliadou E; Moleiro J; Ribaldone DG; Astegiano M; Rothfuss K; Taxonera C; Ghalim F; Carbonnel F; Verstockt B; Festa S; Maia L; Berrozpe A; Zagorowicz E; Savarino E; Ellul P; Vavricka SR; Calvo M; Koutroubakis I; Hoentjen F; Salazar LF; Callela F; Cañete Pizarro F; Soufleris K; Sonnenberg E; Cavicchi M; Wypych J; Hommel C; Ghiani A; Fiorino G;
J Crohns Colitis; 2020 May; 14(4):480-489. PubMed ID: 31602473
[TBL] [Abstract][Full Text] [Related]
53. Current perspective of progressive-fibrosing interstitial lung disease.
Kishaba T
Respir Investig; 2022 Jul; 60(4):503-509. PubMed ID: 35431170
[TBL] [Abstract][Full Text] [Related]
54. Krebs von den Lungen-6 as a biomarker for disease severity assessment in interstitial lung disease: a comprehensive review.
d'Alessandro M; Bergantini L; Cameli P; Vietri L; Lanzarone N; Alonzi V; Pieroni M; M Refini R; Sestini P; Bonella F; Bargagli E
Biomark Med; 2020 Jun; 14(8):665-674. PubMed ID: 32613855
[No Abstract] [Full Text] [Related]
55. Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases.
Perez-Alvarez R; Perez-de-Lis M; Diaz-Lagares C; Pego-Reigosa JM; Retamozo S; Bove A; Brito-Zeron P; Bosch X; Ramos-Casals M
Semin Arthritis Rheum; 2011 Oct; 41(2):256-64. PubMed ID: 21277618
[TBL] [Abstract][Full Text] [Related]
56. [Drug-induced interstitial lung disease: approaches to diagnostics and treatment].
Anaev EK
Ter Arkh; 2020 Apr; 92(3):84-91. PubMed ID: 32598798
[TBL] [Abstract][Full Text] [Related]
57. Clinical Outcomes of Immune Checkpoint Inhibitor Therapy in Patients With Advanced Non-small Cell Lung Cancer and Preexisting Interstitial Lung Diseases: A Systematic Review and Meta-analysis.
Zhang M; Fan Y; Nie L; Wang G; Sun K; Cheng Y
Chest; 2022 Jun; 161(6):1675-1686. PubMed ID: 35026298
[TBL] [Abstract][Full Text] [Related]
58. A cohort study of Danish patients with interstitial lung diseases: burden, severity, treatment and survival.
Hyldgaard C
Dan Med J; 2015 Apr; 62(4):B5069. PubMed ID: 25872544
[TBL] [Abstract][Full Text] [Related]
59. Review: Serum biomarkers in idiopathic pulmonary fibrosis and systemic sclerosis associated interstitial lung disease - frontiers and horizons.
Jee AS; Sahhar J; Youssef P; Bleasel J; Adelstein S; Nguyen M; Corte TJ
Pharmacol Ther; 2019 Oct; 202():40-52. PubMed ID: 31153954
[TBL] [Abstract][Full Text] [Related]
60. Cough is less common and less severe in systemic sclerosis-associated interstitial lung disease compared to other fibrotic interstitial lung diseases.
Cheng JZ; Wilcox PG; Glaspole I; Corte TJ; Murphy D; Hague CJ; Ryerson CJ
Respirology; 2017 Nov; 22(8):1592-1597. PubMed ID: 28544079
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
